[1] |
BAO Lei, GENG Zihan, LI Shuran, JI Zuen, ZHAO Ronghua, SUN Jing, GUO Shanshan, CUI Xiaolan.
The critical role of TRP channels in the progression of viral pneumonia
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 137-140.
|
[2] |
XU Weijia, PENG Qi, HUANG Haiyu, ZHANG Leijiao, XIAO Hua, WU Xue.
285 cases of adverse drug reaction related to new antineoplastic drugs
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 199-203.
|
[3] |
CHEN Yuyan, ZHANG Mingxia, ZHANG Tao, ZHANG Jin.
One case of interstitial pneumonia caused by serplulimab injection
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 213-215.
|
[4] |
CAO Shan, PANG Bo, XU Yingli, ZHANG Jingsheng, CHEN Mengping, ZHANG Yu, WANG Yaxin, BAO Lei, GENG Zihan, GUO Shanshan, ZHAO Ronghua, CUI Xiaolan.
Effects of Shufeng Jiedu capsules prophylactic administration on TLR4-mediated inflammatory injury in lung tissue in a mouse model of inffuenza virus infeciton
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(1): 45-50.
|
[5] |
ZHANG Jingsheng, GAO Shuangrong, PANG Bo, LIU Lina, XU Yingli, CAO Shan, CHEN Mengping, ZHANG Yu, ZHAO Ronghua, CUI Xiaolan.
The mechanism of Sanhan Huashi Granules on pneumonia induced by human coronavirus 229E and OC43 in mice
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(1): 51-54.
|
[6] |
WANG Lyuyin, LI Yi, SUN Yue, HU Xinyue, ZHANG Hui, LI Jing, LIANG Chenggang.
Determination of sialic acid in recombinant human follicle stimulating hormone by high performance liquid chromatography with DMB derivatization
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(1): 89-93.
|
[7] |
ZHANG Li, WANG Yujia, ZHANG Lingling, CHEN Jiaxin, LIN Minhua, LIN Xiaohui, NIE Xuekun.
Surveillance data on adverse reactions associated with real-world immune checkpoint inhibitors
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(9): 1035-1038.
|
[8] |
ZHANG Yuqi, XU Xinyi, ZHU Lan, ZHU Yan.
Comparison standard terminology for pharmaceutical dose forms
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(8): 904-910.
|
[9] |
ZHANG Xialan, YUAN Jing, WU Bin, QIN Yuanyuan.
Medications of apatinib mesylate in patients with malignant tumors
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(8): 927-932.
|
[10] |
WANG Ran, LI Yifan, LIU Xiaoyan, FENG Xin.
One case of pharmaceutical care of drug exposure during pregnancy
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(8): 933-934.
|
[11] |
YU Yuehua, ZHAO Yan, LU Tiangong, SUN Zhenxiao.
Screening and in vitro study of traditional Chinese medicines against lung adenocarcinoma based on EGFR
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(7): 735-741.
|
[12] |
WU Lingfang, TIAN Wei, MA Yongben, GAO Le, SUN Zheng, WANG Xinguo, NIU Liying.
Determination of seven main components in aqueous extract of Bupleuri Radix-Paeoniae Alba Radix by UPLC-PDA
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(7): 769-774.
|
[13] |
ZHANG Lei, LYU Jian, XIE Yanming.
Efficacy and safety of Houpupaiqi Mixture in the treatment of postoperative lieus: a Meta-analysis
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(7): 799-806.
|
[14] |
LIU Jing, XIA Liang, ZHANG Shijie.
Pharmaceutical care of a patient with acute pancreatitis complicated with multiple drug allergy undergoing drug stimulation test
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(7): 822-824.
|
[15] |
QIN Guilan, ZHOU Muzi, JI Zhaoshuai, MAO Qiantai, AI Chao.
One case of acute constipation induced by semaglutide injection
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(7): 833-835.
|